First, Al-Hajj et al. [14] found that CD44+/CD24− breast cancer cells represent distinct characteristics of CSCs, and then several surface markers such as aldehyde dehydrogenase (ALDH), EpCAM, and LGR5 have been reported [15,16]. The gene discussed is CD44; the disease is breast carcinoma.